SUZANNE CHREBET: Open Payments
NPI 1659929164 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 33 payments from 10 companies in 2025. Trend: 2023 $1,166 · 2024 $389 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $211 |
| Lundbeck LLC | 5 | $82 |
| Bausch Health US, LLC | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Alkermes, Inc. | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| ABBVIE INC. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: CAPLYTA, REXULTI, APLENZIN, Auvelity, ARISTADA, AUSTEDO XR, VRAYLAR, FANAPT.
Industry payments across NJ — which companies pay providers there.
